Connect with us

What Is The Newest Treatment For Lung Cancer




Lung cancer is a variation of this atrocious disease that occurs when abnormal cells divide uncontrollably to form a tumor, or multiple tumors, in the lungs.

There has been a significant amount of progress made in the advancement of lung cancer research. This is because scientists are now able to identify many types of genetic alterations that may drive lung cancer growth.

Treatment for this disease often depends on a person’s overall health and lung function, in addition to the aggressiveness of the lung cancer itself.

Though there are many trials taking place, there is still no exact treatment for lung cancer. You can check out Power for more information.

Types Of Lung Cancer

There are several different types of lung cancer. Each is defined by the kind of cell that cancer starts in. Understanding the type of lung cancer someone has may determine the kind of treatment that they should receive.

The two main groups of lung cancer are non-small cell lung cancer (NSCLC) which is the most common type, comprising around 85 to 90% of all known cases of lung cancer, and also small cell lung cancer (SCLC), which constitutes about 10 to 15% of lung cancer cases.

These groups can be split into smaller groups depending on exactly how and where the type of cancer forms.

This includes squamous non-small cell lung cancer, which tends to develop from the flat cells covering the surface of your airways. It also concerns non-squamous non-small cell lung cancer that tends to develop from other cells in the lungs, such as the mucus-creating glands.

Elf- (19)

Symptoms Of Lung Cancer

There are many different symptoms of lung cancer that are targeted by invasive and non-invasive treatment types, yet the most common ones are as follows:

  • Repeat chest infections
  • Persistent breathlessness
  • Coughing blood
  • A recurring cough
  • A long-standing cold that never gets better
  • Lack of energy

Newest Treatments

Treatment options for lung cancer are constantly in development. Some of the most widely-used ones include surgery, chemotherapy, radiation, targeted therapy, immunotherapy, or a combination of all of these options.

Recently, however, there has been a bigger focus on targeted immunotherapy treatment.


Immunotherapy drugs are changing the landscape of treatment for people living with lung cancer. They close down immune checkpoints to make it easier for T cells to correctly identify any cancer.

Each of these immune checkpoint inhibitors works for a specific type of immune pathway. Because of this effectiveness, more immunotherapy options are being developed every year. Some of the newest and most widespread immunotherapy lung cancer treatments include:

  • Atezolizumab
  • Cemiplimab
  • Dostarlimab
  • Durvalumab
  • Ipilimumab
  • Nivolumab
  • Pembrolizumab

According to recent studies, the combination of Pembrolizumab and Guadecitabine, which is a next-generation DNA hypomethylating agent, has also been said to slow the advance of cancer.

Elf- (18)

Anaplastic Lymphoma Kinase (ALK) Inhibitors

These work by targeting the cancer-inducing alteration in the ALK gene that continues to be refined for the total 5% of NSCLC cancer patients who have such an alteration.

In addition to crizotinib (Xalkori) and ceritinib (Zykadia), the following have also been recently approved:

  • Alectinib
  • Brigatinib
  • Lorlatinib

These ALK inhibitors are improvements from previous ones due to their enhanced ability to cross the ever-present blood-brain barrier. This is a critical process because, in NSCLC patients with ALK alterations, a lot of the disease progression will occur within the human brain.

Most Effective Treatment

While researchers continue to look for new treatment options for all stages of lung cancer, scientists currently have some promising results for a treatment for non-small cell lung cancer (NSCLC).

The Medicines and Healthcare products Regulatory Agency (MHRA) and the Food and Drug Administration (FDA) have also now approved the effective therapy called Atezolizumab to treat patients with early-stage NSCLC with tumors that show the PD-L1 mutation.

These patients will also have had surgery and chemotherapy and are the most at-risk of the cancer returning.

This innovative IV drip is given via an IV drip and effectively works as it blocks a specific protein to prevent the immune system from directly attacking the cancer cells in the body. It does this by making these cells far more visible to the immune system.


These are some of the newest ways that some types of lung cancer can be treated after receiving a diagnosis. In recent years, targeted therapies have become widely available for advanced lung cancer. With so many cases of lung cancer year-round, more treatments are in development.

Never seek any of these treatments unless you are receiving regular medical guidance.

Continue Reading